UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Clinical cancer research, 2021-07, Vol.27 (14), p.3896-3904

2021

Volltextzugriff (PDF)

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)

Clinical cancer research, 2021-02, Vol.27 (4), p.975-982

2021

Volltextzugriff (PDF)

Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

Clinical cancer research, 2024-05, Vol.30 (10), p.2160-2169

2024

Volltextzugriff (PDF)

A citizen science project in Ludmilla Bay, Darwin Harbour, helps identify invertebrates that fuel shorebird migration

Northern Territory naturalist, 2021-02, Vol.30, p.15-35

2021

Volltextzugriff (PDF)

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial

JAMA oncology, 2024-02, Vol.10 (2), p.227

2024

Volltextzugriff (PDF)

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

NPJ breast cancer, 2022-07, Vol.8 (1), p.80-80, Article 80

2022

Volltextzugriff (PDF)

Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions

Annals of surgical oncology, 2018-10, Vol.25 (10), p.2948-2952

2018

Volltextzugriff (PDF)

Use of Ultrasound and Ki-67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy

Healthcare (Basel), 2023-02, Vol.11 (3), p.417

2023

Volltextzugriff (PDF)

Musculoskeletal Adverse Events Associated with Adjuvant Aromatase Inhibitors

Journal of oncology, 2010-01, Vol.2010 (2010), p.1-8

2010

Volltextzugriff (PDF)

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease

NPJ breast cancer, 2023-03, Vol.9 (1), p.10-10, Article 10

2023

Volltextzugriff (PDF)

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer

Breast cancer research and treatment, 2010-01, Vol.119 (1), p.111-118

2010

Volltextzugriff (PDF)

Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker Analysis

JCO precision oncology, 2017-11 (1), p.1-6

2017

Volltextzugriff (PDF)

Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer

Breast cancer research : BCR, 2007-01, Vol.9 (3), p.R35-R35, Article R35

2007

Volltextzugriff (PDF)

Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy

Nature cancer, 2021-06, Vol.2 (6), p.658

2021

Volltextzugriff (PDF)

Pupillary response: cognitive effort for breast cancer survivors

Supportive care in cancer, 2019-03, Vol.27 (3), p.1121-1128

2019

Volltextzugriff (PDF)

KANSURVIVE: Testing a telementoring model for improving cancer survivorship care in rural practice

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e13791-e13791

2024

Volltextzugriff (PDF)

Point of care genetic testing in a breast cancer survivorship clinic

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.10580-10580

2021

Volltextzugriff (PDF)

Clinicopathological Characteristics of Triple-Negative Invasive Mammary Carcinomas in African-American versus Caucasian Women

Annals of clinical and laboratory science, 2010-09, Vol.40 (4), p.315-323

2010

Volltextzugriff (PDF)

Safety of limited dose modifications for palbociclib associated neutropenia in ER+ metastatic breast cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13033-e13033

2018

Volltextzugriff (PDF)

Abstract P2-13-34: A phase II trial of lapatinib and everolimus for HER2 positive metastatic breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P2-P2-13-34

2022

Volltextzugriff (PDF)

Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy

Nature cancer, 2021-06, Vol.2 (6), p.658-671

2021

Volltextzugriff (PDF)

Pilot Feasibility Study Examining Pupillary Response During Driving Simulation as a Measure of Cognitive Load in Breast Cancer Survivors

Oncology nursing forum, 2020-03, Vol.47 (2), p.203-212

2020

Volltextzugriff (PDF)

1 – 25 von 98

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(83)

Publikationsform

Sprache

Englisch
(90)
Französisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(45)
Humans
(32)
Female
(24)
Oncology
(19)
Adult
(18)
Middle Aged
(18)
Aged
(12)
Male
(11)
Biological And Medical Sciences
(9)
Patients
(9)
Breast Cancer
(8)
Cancer Therapies
(7)
Treatment Outcome
(7)
Clinical Trials
(6)
Aged, 80 And Over
(5)
Breast Neoplasms - Drug Therapy
(5)
Chemotherapy
(5)
Medical Sciences
(5)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I-III Triple-negative Breast Cancer (NeoSTOP)

Tumor-Infiltrating Lymphocytes Refine Outcomes in Triple-Negative Breast Cancer Treated with Anthracycline-Free Neoadjuvant Chemotherapy

A citizen science project in Ludmilla Bay, Darwin Harbour, helps identify invertebrates that fuel shorebird migration

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer: NeoPACT Phase 2 Clinical Trial

Impact of low versus negative estrogen/progesterone receptor status on clinico-pathologic characteristics and survival outcomes in HER2-negative breast cancer

Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions

Use of Ultrasound and Ki-67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy

A Multicenter Phase II Trial of Ipilimumab and Nivolumab in Unresectable or Metastatic Metaplastic Breast Cancer: Cohort 36 of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART, SWOG S1609)

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Musculoskeletal Adverse Events Associated with Adjuvant Aromatase Inhibitors

ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer

Clinical Activity of Pembrolizumab in a Patient With Metastatic Triple-Negative Breast Cancer Without Tumor Programmed Death-Ligand 1 Expression: A Case Report and Correlative Biomarker Analysis

Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer

Serial single-cell genomics reveals convergent subclonal evolution of resistance as early-stage breast cancer patients progress on endocrine plus CDK4/6 therapy

Pupillary response: cognitive effort for breast cancer survivors

KANSURVIVE: Testing a telementoring model for improving cancer survivorship care in rural practice

Point of care genetic testing in a breast cancer survivorship clinic

Clinicopathological Characteristics of Triple-Negative Invasive Mammary Carcinomas in African-American versus Caucasian Women

Safety of limited dose modifications for palbociclib associated neutropenia in ER+ metastatic breast cancer

Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: MAINTAIN Trial

Abstract P2-13-34: A phase II trial of lapatinib and everolimus for HER2 positive metastatic breast cancer

Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy

Pilot Feasibility Study Examining Pupillary Response During Driving Simulation as a Measure of Cognitive Load in Breast Cancer Survivors

Suchergebnisse filtern